BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2001
View Archived Issues
Serono confirms submission of Rebif amendment to FDA
Read More
Bausch & Lomb acquires loteprednol etabonate line
Read More
FDA issues approvable letter for UroXatral
Read More
CAT and Merck & Co. form HIV alliance
Read More
Maxygen brings two new therapeutics into preclinical pipeline
Read More
Roche's PEGASYS introduced in first market
Read More
Inhibition of p38 MAPK in experimental model of colitis has dual effect
Read More
Efficacy of MAP kinase blocker CNI-1493 in Crohn's disease seen in pilot trial
Read More
Gene therapy with IL-10 produces therapeutic benefit in experimental colitis
Read More
Matrix to initiate new study of tezacitabine in AML
Read More
High-dose ISIS-2302 enemas improve symptoms in ulcerative colitis
Read More
Favorable OvaRex/chemotherapy clinical trial results in relapsed ovarian cancer reported by AltaRex
Read More
First clinical data for new propofol prodrug presented at ASA meeting
Read More
GlycoDesign and Leo move new antithrombotics into clinical trials
Read More
Cardioprotective effects of landiolol and propranolol compared in guinea pig hearts
Read More
MGI Pharma expands phase II irofulven clinical trial in ovarian cancer
Read More
Potential new therapeutic target for endotoxin shock: anandamide
Read More
Cardioprotective and vasodilating effects described for JTV-519 at ASA meeting
Read More
Peregrine's Cotara receives FDA fast track review status
Read More
FDA issues approvable letter for Symlin in type 1 and type 2 diabetes
Read More
New clinical data show Multikine's ability to eliminate HPV-induced cervical dysplasia
Read More
Neuroprotective aminoadamantane derivatives disclosed by Panorama
Read More
New VLA-4 antagonists in the Kaken pipeline
Read More
Selective dopamine D3 receptor antagonists identified by Pharmacia
Read More
Two Japanese patents cover Otsuka's new hypoglycemic/hypolipidemic compounds
Read More
Inhibitors of CDKs useful as anticancer agents
Read More
Antitumor antibiotics discovered at MCRF in Streptomyces
Read More